Abbott Laboratories (ABT)
115.90
+0.87
(+0.76%)
USD |
NYSE |
Nov 15, 16:00
116.37
+0.47
(+0.41%)
After-Hours: 20:00
Abbott Laboratories Research and Development Expense (TTM): 2.795B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.795B |
| June 30, 2024 | 2.754B |
| March 31, 2024 | 2.771B |
| December 31, 2023 | 2.741B |
| September 30, 2023 | 2.766B |
| June 30, 2023 | 2.876B |
| March 31, 2023 | 2.845B |
| December 31, 2022 | 2.888B |
| September 30, 2022 | 2.925B |
| June 30, 2022 | 2.815B |
| March 31, 2022 | 2.785B |
| December 31, 2021 | 2.742B |
| September 30, 2021 | 2.678B |
| June 30, 2021 | 2.586B |
| March 31, 2021 | 2.496B |
| December 31, 2020 | 2.42B |
| September 30, 2020 | 2.317B |
| June 30, 2020 | 2.333B |
| March 31, 2020 | 2.346B |
| December 31, 2019 | 2.44B |
| September 30, 2019 | 2.407B |
| June 30, 2019 | 2.385B |
| March 31, 2019 | 2.383B |
| December 31, 2018 | 2.30B |
| September 30, 2018 | 2.357B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.351B |
| March 31, 2018 | 2.296B |
| December 31, 2017 | 2.26B |
| September 30, 2017 | 2.009B |
| June 30, 2017 | 1.793B |
| March 31, 2017 | 1.621B |
| December 31, 2016 | 1.447B |
| September 30, 2016 | 1.448B |
| June 30, 2016 | 1.474B |
| March 31, 2016 | 1.471B |
| December 31, 2015 | 1.405B |
| September 30, 2015 | 1.397B |
| June 30, 2015 | 1.324B |
| March 31, 2015 | 1.289B |
| December 31, 2014 | 1.345B |
| September 30, 2014 | 1.343B |
| June 30, 2014 | 1.377B |
| March 31, 2014 | 1.43B |
| December 31, 2013 | 1.407B |
| September 30, 2013 | 1.425B |
| June 30, 2013 | 1.437B |
| March 31, 2013 | 1.444B |
| December 31, 2012 | 1.462B |
| September 30, 2012 | -380.84M |
| June 30, 2012 | 278.14M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
2.317B
Minimum
Sep 2020
2.925B
Maximum
Sep 2022
2.666B
Average
2.748B
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.519B |
| Becton Dickinson & Co | 1.19B |
| ResMed Inc | 311.34M |
| Globus Medical Inc | 182.60M |
| Insulet Corp | 201.00M |